Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Noriko Tsubooka-Yamazoe"'
Autor:
Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Kiyohiro Hashimoto, Nozomu Sakai, Shinya Asano, Saori Watanabe-Matsumoto, Takeshi Watanabe, Bunnai Saito, Hirokazu Matsumoto, Hikaru Ueno, Ryo Ito, Taro Toyoda
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background Transplantation of differentiated cells from human-induced pluripotent stem cells (hiPSCs) holds great promise for clinical treatments. Eliminating the risk factor of malignant cell transformation is essential for ensuring the saf
Externí odkaz:
https://doaj.org/article/a21dd5df379540a8874afc1118b6fef0
Autor:
Hideyuki Hiyoshi, Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Shinya Asano, Taisuke Mochida, Junji Yamaura, Shuhei Konagaya, Ryo Fujii, Hirokazu Matsumoto, Ryo Ito, Taro Toyoda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract The differentiation of pancreatic endocrine cells from human pluripotent stem cells has been thoroughly investigated for their application in cell therapy against diabetes. Although non-endocrine cells are inevitable contaminating by-product
Externí odkaz:
https://doaj.org/article/230766f713d141caa8dc083eae065981
Autor:
Taisuke Mochida, Noriko Tsubooka-Yamazoe, Hideyuki Hiyoshi, Hikaru Ueno, Hirokazu Matsumoto, Ryo Ito, Taro Toyoda
Publikováno v:
Diabetes. 69(4)
The host environment is a crucial factor for considering the transplant of stem cell–derived immature pancreatic cells in patients with type 1 diabetes. Here, we investigated the effect of insulin (INS)-deficient diabetes on the fate of immature pa
Autor:
Taisuke Mochida, Hikaru Ueno, Noriko Tsubooka-Yamazoe, Hideyuki Hiyoshi, Ryo Ito, Hirokazu Matsumoto, Taro Toyoda, Mochida, Taisuke, Ueno, Hikaru, Yamazoe, Noriko, Hiyoshi, Hideyuki, Ito, Ryo, Matsumoto, Hirokazu, Toyoda, Taro, Tsubooka-Yamazoe, Noriko
Publikováno v:
Diabetes; Apr2020, Vol. 69 Issue 4, p634-646, 13p
Publikováno v:
Stem Cell Research. 8(2):274-284
Human induced pluripotent stem (hiPS) cells have potential uses for drug discovery and cell therapy, including generation of pancreatic β-cells for diabetes research and treatment. In this study, we developed a simple protocol for generating insulin